ArticleInternational journal of clinical pharmacy2025
Evaluating the economic impact of clinical pharmacist interventions in the women's health setting in Qatar.
Article in International journal of clinical pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of a pharmacist-led elective caesarean section pre-admission clinic on efficiency of pharmacist workflow and patient preparedness for post-operative discharge medication supply: a retrospective observational study.International journal of clinical pharmacy · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundAdverse drug events (ADEs) resulting from nonoptimized medication therapy significantly drive-up healthcare costs. Clinical pharmacists are pivotal in managing medication regimens, effectively reducing these associated expenses.
aimGiven the scarcity of similar studies in the region, this study aimed to evaluate the overall economic impact of clinical pharmacists' interventions against ADEs at the Women's Wellness and Research Center (WWRC) in Qatar.
methodAnalysis of the total economic benefit of clinical pharmacists' interventions was performed through a retrospective chart review of patients' records admitted during the periods of March 2018, July-August 2018, and January 2019. The current analysis was based on WWRC's perspective, in which the cost savings and cost avoidance associated with the interventions were used to determine the total economic benefit. A sensitivity analysis was conducted to determine the robustness of the results. The study was approved at the main public healthcare provider.
resultsA total of 331 interventions for 162 patients were included in the analysis. The total economic benefit was estimated to be QAR169,320 (USD46,503), comprising cost avoidance of QAR170,995 (USD46,964) and negative resource-use cost savings of QAR-1675 (USD-460). The increase in resource use was primarily due to the addition of other medications to therapy. The sensitivity analysis confirmed that the outcomes are robust, demonstrating a 100% probability for positive economic benefits in all simulated cases.
conclusionAlthough there was an observed increase in resource utilization resulting from clinical pharmacists' interventions, this study highlights their crucial role in mitigating the costs associated with preventable adverse drug events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.